Skip to Main Content

Paper Details

Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function.
J Am Heart Assoc
30
2017
13N, Diabetic, Obstructive Coronary Artery Disease, Patients, Ranolazine, ammonia, coronary artery disease, coronary atherosclerosis, diabetes mellitus, diabetic, diastolic dysfunction, microvascular dysfunction, myocardial ischemia, obstructive, obstructive coronary artery disease, patients, ranolazine
Author NameAffiliation
Nishant R ShahHeart and Vascular Institute, Brigham and Women's Hospital, Harvard Medical School
Nishant R ShahLifespan Cardiovascular Institute, Brown University Alpert School of Medicine
David A MorrowHeart and Vascular Institute, Brigham and Women's Hospital, Harvard Medical School
David A MorrowHeart and Vascular Institute, Brigham and Women's Hospital, Harvard Medical School
  • 1 - 4

Datasets

Release 1.2